Severe fetal thrombocytopenia in Rhesus D alloimmunized pregnancies

American Journal of Obstetrics and Gynecology

Volumn 199, Issue 4, 2008, Pages 387.e1-387.e4

  van den Akker, Eline S A ^a   de Haan, Timo R ^c   Lopriore, Enrico ^a   Brand, Anneke ^a,b   Kanhai, Humphrey H H ^a   Oepkes, Dick ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Sanquin Bloedbank Regio Zuidwest Rotterdam   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

fetal blood sampling; hydrops; Rhesus D alloimmunization; thrombocytopenia

Indexed keywords

HEMOGLOBIN F; RHESUS D ANTIBODY; RHESUS D ANTIGEN;

ALLOIMMUNIZATION; ARTICLE; BIRTH WEIGHT; CORDOCENTESIS; DISEASE SEVERITY; FETUS; FETUS BLOOD SAMPLING; FETUS HYDROPS; FETUS MORTALITY; GESTATIONAL AGE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; PREGNANCY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

EID: 52949137059     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2008.07.001     Document Type: Article

References (11)

1. Van den Hof M.C., and Nicolaides K.H. Platelet count in normal, small, and anemic fetuses. Am J Obstet Gynecol 162 (1990) 735-739
2. Segal M., Manning F.A., Harman C.R., and Menticoglou S. Bleeding after intravascular transfusion: Experimental and clinical observations. Am J Obstet Gynecol 165 (1991) 1414-1418
3. Saade G.R., Moise Jr. K.J., Copel J.A., Belfort M.A., and Carpenter Jr. R.J. Fetal platelet counts correlate with the severity of the anemia in red-cell alloimmunization. Obstet Gynecol 82 (1993) 987-991
4. Hohlfeld P., Forestier F., Kaplan C., Tissot J.D., and Daffos F. Fetal thrombocytopenia: A retrospective survey of 5,194 fetal blood samplings. Blood 84 (1994) 1851-1856
5. Jhawar B.S., Ranger A., Steven D., and Del Maestro R.F. Risk factors for intracranial hemorrhage among full-term infants: A case-control study. Neurosurgery 52 (2003) 581-590
6. Van den Akker E.S.A., Klumper F.J.C.M., Brand A., Kanhai H.H.H., and Oepkes D. Kell alloantibodies in pregnancy do not cause fetal thrombocytopenia. Vox Sang 95 (2008) 66-69
7. Van Kamp I.L., Klumper F.J.C.M., Meerman R.H., Oepkes D., Scherjon S.A., and Kanhai H.H.H. Treatment of fetal anaemia due to red-cell alloimmunization with intrauterine transfusions in the Netherlands, 1988-1999. Acta Obstet Gynecol Scand 83 (2004) 731-737
8. Van Kamp I.L., Klumper F.J.C.M., Bakkum R.S.L.A., et al. The severity of immune fetal hydrops is predictive of fetal outcome after intrauterine treatment. Am J Obstet Gynecol 185 (2001) 668-673
9. Van Kamp I.L., Klumper F.J., Oepkes D., et al. Complications of intrauterine intravascular transfusions for fetal anemia due to maternal red cell alloimmunization. Am J Obstet Gynecol 192 (2005) 171-177
10. Overton T.G., Duncan K.R., Jolly M., Letsky E., and Fisk N.M. Serial aggressive platelet transfusion for fetal alloimmune thrombocytopenia: Platelet dynamics and perinatal outcome. Am J Obstet Gynecol 186 (2002) 826-831
11. Berkowitz R.L., Kolb E.A., McFarland J.G., et al. Parallel randomized trials of risk-based therapy for fetal alloimmune thrombocytopenia. Obstet Gynecol 07 (2006) 91-96